View Point Medical, Inc.
USPTO PatentsView assignee record - 6 granted patents across 2 technology areas, recorded in grant years 2021–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).
The verdict
According to USPTO PatentsView, View ranks #43,947 of 49,997 tracked US assignees by granted-patent volume, with 6 patents across 2 technology areas.
- #43,947
- of 49,997 US assignees by volume
- Top 22%
- by Innovation Score (46.0/100)
- 23.8
- avg claims per patent
USPTO PatentsView assignee plate
Corpus R43947 · US Corporation #43,947 · 6 grants
GRANTS-MICRO · LOWER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-DENSE · TYPE-USCORP · SPAN-YRS · BOOK-RICH
- GRANTS-MICRO 6 grants
- LOWER-Q #43,947/49,997
- PHOTO-FINISH Veritas
- CPC-NARROW A61B · 2 areas
- INNOV-PAR 46.0/100
- CLAIMS-DENSE 23.8 claims/avg
- TYPE-USCORP US Corporation
- SPAN-YRS 2021–2025 · 5y
- BOOK-RICH 9/10 fields
Nearest grant-volume peer: Veritas AG (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How View’s 46.0 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around View
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- View Point Medical · this assignee
View Point Medical · this assignee
46 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows View's Innovation Score is 46.0/100 (top 22% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for View?
Each dot is one of View’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). View’s own 23.8 claims/patent is ABOVE the 13.5 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.
Where View's grants concentrate
View Point Medical, Inc. is a focused PatentsView assignee: 2 CPC subclasses with 100% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2024 (3 grants) versus a trough of 1 in 2021. By volume, View sits between Veritas AG and Virchow Biotech Pvt. Ltd..
View's three-year grant acceleration
View Point Medical, Inc. shows 4 grants in 2022–2024 against only 1 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Who files at View's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Veritas
Veritas AG
6 patents
- Versatile Power
Versatile Power, Inc.
6 patents
- Vertellus Special…
Vertellus Specialties Inc.
6 patents
- Vestel Beyaz Esya…
Vestel Beyaz Esya Sanayi ve Ticaret Anonim Sirketi
6 patents
- Vigilant IP Holdi…
Vigilant IP Holdings LLC
6 patents
- Vinnolit & KG
Vinnolit GmbH & Co. KG
6 patents
- Vionx Energy
Vionx Energy Corporation
6 patents
- Virchow Biotech P…
Virchow Biotech Pvt. Ltd.
6 patents
- View Point Medical ◀
View Point Medical, Inc.
6 patents
What this shows View holds 6 patents at rank #43,949, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near View
By rank, the assignees closest to #43,949 in granted patent volume.
- Veritas AG #43,945 · 6 patents
- Versatile Power, Inc. #43,946 · 6 patents
- Vertellus Specialties Inc. #43,947 · 6 patents
- Vestel Beyaz Esya Sanayi ve Ticaret Anonim Sirketi #43,948 · 6 patents
- Vigilant IP Holdings LLC #43,950 · 6 patents
- Vinnolit GmbH & Co. KG #43,951 · 6 patents
- Vionx Energy Corporation #43,952 · 6 patents
- Virchow Biotech Pvt. Ltd. #43,953 · 6 patents
Leaders in A61B (Diagnosis)
Other assignees with the most granted patents in View's primary technology class.
- Covidien LP 5,709 in class
- Koniniklijke Philips N.V. 3,414 in class
- Olympus Corporation 2,758 in class
- Boston Scientific Scimed, Inc. 2,362 in class
- Cilag GmbH International 2,063 in class
- Intuitive Surgical Operations, Inc. 1,921 in class
- DePuy Synthes Products, Inc. 1,796 in class
- Ethicon, Inc. 1,762 in class
View's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
46 Top 22% higher than 78% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2021–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2021 | 1 | 16.7% |
| 2022 | 1 | 16.7% |
| 2024 | 3 | 50.0% |
| 2025partial year | 1 | 16.7% |
Which technologies does View Point Medical, Inc. patent most?
Top 2 of 2 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
View Point Medical, Inc.'s patent record in context - here's where to go next.
- View Point Medical, Inc.'s lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 100% of its portfolio - see every assignee active in that class. Explore A61B
- Ranked #43,947 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare View Point Medical, Inc. against Veritas AG, an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 46.0/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.